Retatrutide (GLP‑1/GIP/Glucagon)
Price range: $815.00 through $1,025.00
Experience the next generation of weight loss therapy with a one-time, compounded dose of Retatrutide — a triple-agonist designed to reduce appetite, increase energy expenditure, and support powerful metabolic results. This trial option is ideal for patients who are curious about Retatrutide but prefer to start with a low-risk, one-time dose under medical supervision.
- Active Ingredient: Compounded Retatrutide (GLP-1/GIP/Glucagon receptor agonist)
- Form: Injection (single-dose vial or prefilled syringe, based on pharmacy)
- Consultation: Required; medication will be prescribed only if clinically appropriate
- Shipping: Delivered discreetly to your door following approval
What is Retatrutide?
Retatrutide is an investigational triple hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors — offering a new frontier in medical weight loss. While still undergoing clinical research, early studies show promising results in reducing body weight and improving metabolic health. It works by:
Suppressing appetite and cravings
Increasing energy expenditure through glucagon activity
Promoting satiety and slowing digestion
Supporting healthy blood sugar and insulin sensitivity
Who Is This For?
You may be eligible for this one-time trial if:
You have a BMI of 30 or higher
Or a BMI of 27 or higher with a weight-related condition
(e.g. high blood pressure, PCOS, insulin resistance)
You are not currently taking any GLP-1, GIP, or glucagon-based therapies
You want to explore Retatrutide before committing to an ongoing treatment program
What’s Included
With your one-time purchase, you’ll receive:
A comprehensive medical consultation with a licensed provider
A one-time dose of compounded Retatrutide
(if approved)
Personalized dosing guidance and safety instructions
Ongoing support from the Amazing Meds care team to help you decide on next steps
There are no hidden fees, no recurring billing, and no subscriptions — unless you choose to continue.
Why Start With One Dose?
- Try this emerging therapy safely under medical supervision
- Monitor your body’s response and tolerability
- Understand possible side effects before starting a full program
- Make an informed decision with full clinical support
Frequently Asked Questions (FAQs)
As of now, Retatrutide is considered investigational and is undergoing clinical studies. However, we offer compounded formulations when deemed appropriate by a licensed medical provider.
No. Retatrutide is a newer compound that targets three receptors (GLP-1, GIP, and glucagon), whereas those medications target one or two. Retatrutide may offer broader metabolic benefits.
For this one-time trial, lab work is not required, although your provider may recommend testing depending on your health history.
No. This is a one-time dose. There are no automatic subscriptions or ongoing charges unless you choose to continue treatment.
Triple-agonists like Retatrutide are designed to enhance weight loss results by targeting multiple pathways — controlling appetite, improving insulin response, and increasing metabolism.
It’s an injectable treatment, provided in either a prefilled syringe or single-dose vial. Instructions are included and your provider will guide you through proper use.
You’ll receive follow-up support from our care team to evaluate your experience and determine whether a full program is a good fit.
Your safety is our priority. You’ll be evaluated by a licensed provider, and medication will only be prescribed if it’s considered appropriate for your health profile.
